文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

血浆联合给药改善猪失血性休克模型中氨甲环酸或凝血酶原复合物的复苏效果

Plasma coadministration improves resuscitation with tranexamic acid or prothrombin complex in a porcine hemorrhagic shock model.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论在猪失血性休克模型中,血浆联合氨甲环酸或凝血酶原复合物在改善酸中毒、凝血病和凝血时间方面优于单用或不用血浆的联合方案。

该研究采用60头成年猪建立35%血容量失血联合躯干缺血再灌注损伤模型,随机分为对照组(n=12)、单药组(氨甲环酸n=10、凝血酶原复合物n=8、新鲜冰冻血浆n=6)及联合组(氨甲环酸-新鲜冰冻血浆n=10、凝血酶原复合物-新鲜冰冻血浆n=8、氨甲环酸-凝血酶原复合物n=6),复苏持续至6小时。所有动物均存活至6小时。含新鲜冰冻血浆组复苏和凝血参数显著改善:6.5小时乳酸较低(6.5 vs 8.4,p=0.04),纤维蛋白原较高(126 vs 95,p<0.01),旋转血栓弹力图凝血时间缩短(60秒 vs 65秒,p=0.04)。作者认为,新鲜冰冻血浆联合氨甲环酸或凝血酶原复合物在纠正创伤性凝血病方面优于单用或不用血浆的联合方案,纯因子策略需进一步验证。

要点

  • 在猪失血性休克模型中,含新鲜冰冻血浆组6.5小时乳酸为6.5,非血浆组为8.4(p=0.04),提示血浆联合改善酸中毒。
  • 含新鲜冰冻血浆组6小时纤维蛋白原为126,非血浆组为95(p<0.01),血浆联合组纤维蛋白原更高。
  • 旋转血栓弹力图显示含新鲜冰冻血浆组凝血时间为60秒,非血浆组为65秒(p=0.04),血浆联合组凝血时间缩短。
  • 所有60头动物均存活至6小时,组间pH(p=0.02)、INR(p<0.01)、凝血时间(p<0.01)、乳酸(p=0.01)、肌酐(p<0.01)和纤维蛋白原(p=0.02)存在显著差异。
  • 作者认为,新鲜冰冻血浆联合氨甲环酸或凝血酶原复合物在纠正创伤性凝血病方面优于单用或不用血浆的联合方案,纯因子策略需进一步验证。

适用人群与场景

  • 成年猪(60头)建立35%血容量失血联合躯干缺血再灌注损伤模型,用于研究创伤性凝血病的复苏策略。

处置流程与药物剂量

  • 动物随机分为对照组(n=12)、单药组(氨甲环酸n=10、凝血酶原复合物n=8、新鲜冰冻血浆n=6)及联合组(氨甲环酸-新鲜冰冻血浆n=10、凝血酶原复合物-新鲜冰冻血浆n=8、氨甲环酸-凝血酶原复合物n=6),复苏持续至6小时。

研究设计与关键结果

  • 研究类型为动物实验(猪失血性休克模型),样本量60头,随机分为对照组(n=12)、单药组(氨甲环酸n=10、凝血酶原复合物n=8、新鲜冰冻血浆n=6)及联合组(氨甲环酸-新鲜冰冻血浆n=10、凝血酶原复合物-新鲜冰冻血浆n=8、氨甲环酸-凝血酶原复合物n=6)。
  • 所有60头动物均存活至6小时。
  • 休克表现为低血压(平均动脉压44 mm Hg)、心动过速(心率145)、酸中毒(pH 7.18;乳酸11)、贫血(血细胞比容17)和凝血病(纤维蛋白原107)。
  • 组间平均pH(p=0.02)、国际标准化比值(p<0.01)、凝血时间(p<0.01)、乳酸(p=0.01)、肌酐(p<0.01)和纤维蛋白原(p=0.02)存在显著差异。
  • 含新鲜冰冻血浆组6.5小时乳酸为6.5,非血浆组为8.4(p=0.04);含新鲜冰冻血浆组6小时纤维蛋白原为126,非血浆组为95(p<0.01)。
  • 旋转血栓弹力图显示含新鲜冰冻血浆组凝血时间为60秒,非血浆组为65秒(p=0.04)。

证据类型、等级与局限

  • 证据类型:动物实验(猪失血性休克模型)。
  • 作者结论:新鲜冰冻血浆联合氨甲环酸或凝血酶原复合物在纠正创伤性凝血病方面优于单用或不用血浆的联合方案;纯因子策略需进一步验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在纠正创伤性凝血病时,新鲜冰冻血浆联合氨甲环酸或凝血酶原复合物在改善酸中毒、凝血病和凝血时间方面优于单用这些药物或不用血浆的联合方案。
  • 作者指出,纯因子策略需进一步验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic coagulopathy has now been well characterized and carries high rates of mortality owing to bleeding. A 'factor-based' resuscitation strategy using procoagulant drugs and factor concentrates in lieu of plasma is being used by some, but with little evidentiary support. We sought to evaluate and compare resuscitation strategies using combinations of tranexamic acid (TXA), prothrombin complex concentrate (PCC), and fresh frozen plasma (FFP).

METHODS: Sixty adult swine underwent 35% blood volume hemorrhage combined with a truncal ischemia-reperfusion injury to produce uniform shock and coagulopathy. Animals were randomized to control (n = 12), a single-agent group (TXA, n = 10; PCC, n = 8; or FFP, n = 6) or combination groups (TXA-FFP, n = 10; PCC-FFP, n = 8; TXA-PCC, n = 6). Resuscitation was continued to 6 hours. Key outcomes included hemodynamics, laboratory values, and rotational thromboelastometry. Results were compared between all groups, with additional comparisons between FFP and non-FFP groups.

RESULTS: All 60 animals survived to 6 hours. Shock was seen in all animals, with hypotension (mean arterial pressure, 44 mm Hg), tachycardia (heart rate, 145), acidosis (pH 7.18; lactate, 11), anemia (hematocrit, 17), and coagulopathy (fibrinogen, 107). There were clear differences between groups for mean pH (p = 0.02), international normalized ratio (p < 0.01), clotting time (CT; p < 0.01), lactate (p = 0.01), creatinine (p < 0.01), and fibrinogen (p = 0.02). Fresh frozen plasma groups had significantly improved resuscitation and clotting parameters (Figures), with lower lactate at 6.5 versus 8.4 (p = 0.04), and increased fibrinogen at 126 versus 95 (p < 0.01). Rotational thromboelastometry also demonstrated shortened CT at 60 seconds in the FFP group vs 65 seconds in the non-FFP group (p = 0.04).

CONCLUSION: When used to correct traumatic coagulopathy, combinations of FFP with TXA or PCC were superior in improving acidosis, coagulopathy, and CT than when these agents are given alone or in combination without plasma. Further validation of pure factor-based strategies is needed.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Kuckelman J, Barron M, Moe D, et al. Plasma coadministration improves resuscitation with tranexamic acid or prothrombin complex in a porcine hemorrhagic shock model. J Trauma Acute Care Surg. 2018. PMID: 29958247. doi:10.1097/TA.0000000000001942

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。